David Melnick
Overview
David Melnick received an average of $1M in total compensation, including $382K in salary, at Spero Therapeutics between 2018 and 2019.
Source: SEC filings on September 30, 2020 and April 26, 2019.
Related executives
We found six more executives who work or worked at Spero Therapeutics.
Ankit Mahadevia
Spero Therapeutics
Chief Executive Officer
Satyavrat Shukla
Spero Therapeutics
Chief Executive Officer
Tamara Joseph
Spero Therapeutics
Chief Legal Officer
Cristina Larkin
Spero Therapeutics
Chief Operating Officer
Christina Larkin
Spero Therapeutics
Chief Operating Officer
Joel Sendek
Spero Therapeutics